NCM
BMY icon

Nelson Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Nelson Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,028
Closed -$154K – 123
2019
Q3 		$154K Buy
3,028
+710
+31% +$33.4K 0.04% 101
2019
Q2 		$105K Sell
2,318
-30
-1% -$1.4K 0.02% 113
2019
Q1 		$112K Sell
2,348
-84,237
-97% -$4.2M 0.03% 102
2018
Q4 		$4.5M Sell
86,585
-4,340
-5% -$233K 1.25% 33
2018
Q3 		$5.64M Buy
90,925
+1,680
+2% +$99.7K 1.3% 36
2018
Q2 		$4.94M Buy
89,245
+2,347
+3% +$127K 1.27% 39
2018
Q1 		$5.5M Sell
86,898
-360
-0.4% -$23.2K 1.42% 30
2017
Q4 		$5.35M Sell
87,258
-67
-0.1% -$4.19K 1.67% 32
2017
Q3 		$5.57M Buy
87,325
+585
+0.7% +$34.2K 1.83% 25
2017
Q2 		$4.83M Buy
86,740
+84,340
+3,514% +$4.59M 1.64% 30
2017
Q1 		$131K Hold
2,400
– – 0.04% 98
2016
Q4 		$140K Hold
2,400
– – 0.05% 91
2016
Q3 		$129K Buy
2,400
+1,360
+131% +$87.4K 0.05% 94
2016
Q2 		$76K Hold
1,040
– – 0.03% 100
2016
Q1 		$66K Hold
1,040
– – 0.02% 101
2015
Q4 		$72K Hold
1,040
– – 0.03% 96
2015
Q3 		$62K Sell
1,040
-40
-4% -$2.54K 0.02% 102
2015
Q2 		$72K Buy
+1,080
New +$71.2K 0.03% 103
2015
Q1 		– Sell
-1,117
Closed -$66K – 274
2014
Q4 		$66K Sell
1,117
-456
-29% -$25.7K 0.02% 113
2014
Q3 		$81K Buy
1,573
+793
+102% +$39.6K 0.03% 105
2014
Q2 		$38K Buy
780
+520
+200% +$25.6K 0.02% 134
2014
Q1 		$13K Buy
+260
New +$13.8K 0.01% 183

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Nelson Capital Management's BMY Position: Q4 2019 in Review

Nelson Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2019, closing a stake of 3,028 shares — an estimated $154K sold.

Nelson Capital Management first reported a position in BMY in Q1 2014 and held it in 22 quarters. The position peaked at $5.64M in Q3 2018. 2,218 funds tracked by Wall St. Rank hold BMY as of Q4 2019.

  • Nelson Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2019 after selling out during the quarter.
  • Nelson Capital Management sold 3,028 Bristol-Myers Squibb shares in Q4 2019, an estimated $154K.
  • Nelson Capital Management first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 22 quarters.
  • Nelson Capital Management's Bristol-Myers Squibb position peaked at $5.64M in Q3 2018.
  • 2,218 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.

Based on Nelson Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.